Ceramide Recruits and Activates Protein Kinase C ζ (PKCζ) within Structured Membrane Microdomains

Todd E. Fox, Kristy L. Houck, Sean O’Neill, Murali Nagarajan, T. Stöver, Pawel T. Pomianowski, Onur Unal, Jong K. Yun, Stanley J. Naides, Mark Kester

Journal of Biological Chemistry · 2007 · 182 citations · 36 references

DOIFull text

Open access

Concepts

Abstract

We have previously demonstrated that hexanoyl-d-erythro-sphingosine (C6-ceramide), an anti-mitogenic cell-permeable lipid metabolite, limited vascular smooth muscle growth by abrogating trauma-induced Akt activity in a stretch injury model of neointimal hyperplasia. Furthermore, ceramide selectively and directly activated protein kinase C ζ (PKCζ) to suppress Akt-dependent mitogenesis. To further analyze the interaction between ceramide and PKCζ, the ability of ceramide to localize within highly structured lipid microdomains (rafts) and activate PKCζ was investigated. Using rat aorta vascular smooth muscle cells (A7r5), we now demonstrate that C6-ceramide treatment results in an increased localization and phosphorylation of PKCζ within caveolin-enriched lipid microdomians to inactivate Akt. In addition, ceramide specifically reduced the association of PKCζ with 14-3-3, a scaffold protein localized to less structured regions within membranes. Pharmacological disruption of highly structured lipid microdomains resulted in abrogation of ceramide-activated, PKCζ-dependent Akt inactivation, whereas molecular strategies suggest that ceramide-dependent PKCζ phosphorylation of Akt3 at Ser34 was necessary for ceramide-induced vascular smooth muscle cell growth arrest. Taken together, these data demonstrate that structured membrane microdomains are necessary for ceramide-induced activation of PKCζ and resultant diminished Akt activity, leading to vascular smooth muscle cell growth arrest. We have previously demonstrated that hexanoyl-d-erythro-sphingosine (C6-ceramide), an anti-mitogenic cell-permeable lipid metabolite, limited vascular smooth muscle growth by abrogating trauma-induced Akt activity in a stretch injury model of neointimal hyperplasia. Furthermore, ceramide selectively and directly activated protein kinase C ζ (PKCζ) to suppress Akt-dependent mitogenesis. To further analyze the interaction between ceramide and PKCζ, the ability of ceramide to localize within highly structured lipid microdomains (rafts) and activate PKCζ was investigated. Using rat aorta vascular smooth muscle cells (A7r5), we now demonstrate that C6-ceramide treatment results in an increased localization and phosphorylation of PKCζ within caveolin-enriched lipid microdomians to inactivate Akt. In addition, ceramide specifically reduced the association of PKCζ with 14-3-3, a scaffold protein localized to less structured regions within membranes. Pharmacological disruption of highly structured lipid microdomains resulted in abrogation of ceramide-activated, PKCζ-dependent Akt inactivation, whereas molecular strategies suggest that ceramide-dependent PKCζ phosphorylation of Akt3 at Ser34 was necessary for ceramide-induced vascular smooth muscle cell growth arrest. Taken together, these data demonstrate that structured membrane microdomains are necessary for ceramide-induced activation of PKCζ and resultant diminished Akt activity, leading to vascular smooth muscle cell growth arrest. A common response to inflammation or stress is the formation of ceramide, an anti-mitogenic, pro-apoptotic lipid metabolite. Ceramide suppresses vascular smooth muscle (VSM) 4The abbreviations used are: VSM, vascular smooth muscle; C6-ceramide or C6, hexanoyl-d-erythro-sphingosine; NBD-C6-ceramide, N-(6-((7-nitro-2-1,3-benzoxadiazol-4-yl)amino)hexanoyl)-d-erythro-sphingosine; PKCζ, protein kinase C ζ, pPKCζ, phosphorylated PKCζ; PDGF, platelet-derived growth factor; MES, 4-morpholineethanesulfonic acid; PP2A, protein phosphatase; MβCD, methyl-β-cyclodextrin; MBS, MES-buffered saline. cell mitogenesis in vitro and in vivo (1Charles R. Sandirasegarane L. Yun J. Bourbon N. Wilson R. Rothstein R.P. Levison S.W. Kester M. Circ. Res. 2000; 87: 282-288Crossref PubMed Scopus (54) Google Scholar, 2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). The initial mechanisms by which ceramide leads to suppression of mitogenesis have not yet been defined. Both biophysical (lipid microdomains) and biochemical (ceramide binding targets) mechanisms have been proposed to address this issue. The present study presents an integrated version of these theories. Published and preliminary data demonstrate that protein kinase C ζ (PKCζ) is a direct and selective target for ceramide (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar, 3Bourbon N.A. Yun J. Kester M. J. Biol. Chem. 2000; 275: 35617-35623Abstract Full Text Full Text PDF PubMed Scopus (196) Google Scholar, 4Wang Y.M. Seibenhener M.L. Vandenplas M.L. Wooten M.W. J. Neurosci. Res. 1999; 55: 293-302Crossref PubMed Scopus (125) Google Scholar, 5Wang G. Silva J. Krishnamurthy K. Tran E. Condie B.G. Bieberich E. J. Biol. Chem. 2005; 280: 26415-26424Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar, 6Muller G. Ayoub M. Storz P. Rennecke J. Fabbro D. Pfizenmaier K. EMBO J. 1995; 14: 1961-1969Crossref PubMed Scopus (475) Google Scholar) and that ceramide-activated PKCζ is necessary for inactivation of Akt-dependent mitogenesis in vascular smooth muscle cells (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). These results have been recapitulated in vivo where cell-permeable ceramide analogues function as novel therapeutics to limit VSM cell growth, in part by abrogating trauma-induced Akt activity in a model of neointimal hyperplasia after stretch injury (1Charles R. Sandirasegarane L. Yun J. Bourbon N. Wilson R. Rothstein R.P. Levison S.W. Kester M. Circ. Res. 2000; 87: 282-288Crossref PubMed Scopus (54) Google Scholar). PKCζ is an atypical isoform of the PKC superfamily and is directly or indirectly regulated by several lipids including ceramides and phosphatidylinositol 3,4,5-trisphosphate but not by diacylglycerol and calcium (7Hirai T. Chida K. J. Biochem. (Tokyo). 2003; 133: 1-7Crossref PubMed Scopus (265) Google Scholar). Generally, PKCs reside in the cytosol and translocate to membranes upon stimulation to interact with activating lipid cofactors. PKCζ may be directly recruited to membranes via interactions with the C1 domain or indirectly recruited to membranes by formation of complexes with PDK1 and scaffolding proteins (7Hirai T. Chida K. J. Biochem. (Tokyo). 2003; 133: 1-7Crossref PubMed Scopus (265) Google Scholar). As lipid micro- and macrodomains have been identified as “signaling hot-spots,” we investigated the roles of ceramide-enriched microdomains in the activation of PKCζ and subsequent inhibition of cellular proliferation via Akt inactivation. Materials and Cell Culture—Hexanoyl-d-erythro-sphingosine (C6-ceramide) was purchased from Avanti Polar Lipids (Alabaster, AL). Hexanoyl-d-erythro-sphingosine [hexanoyl-6-3H] was obtained from American Radiolabeled Chemicals (St. Louis, MO), and recombinant human PDGF-BB was purchased from R&D Systems, Inc (Minneapolis, MN). Anti-Akt, phosphorylated Akt (Ser473), and phosphorylated PKCζ (Thr410) antibodies were purchased from Cell Signaling Technology, Inc. (Beverly, MA). Anti-PKCζ, 14-3-3 pan, and caveolin-1 antibodies were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). The anti-FLAG epitope antibody was purchased from Cayman Chemicals (Ann Arbor, MI). For Western blotting, 4–12% precasted SDS-polyacrylamide gel electrophoresis gradient gels were obtained from Invitrogen, and enhanced chemiluminescence reagent was purchased from Amersham Biosciences. [3H]Thymidine was purchased from MP Biomedicals (Irvine, CA). Methyl-β-cyclodextrin and other chemicals were purchased from Sigma-Aldrich. All cell culture media and reagents were purchased from Invitrogen. Rat embryonic thoracic aorta smooth muscle cells (A7r5) were obtained from American Type Culture Collection (Manassas, VA) and cultured as described previously (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). Cells were treated as described in the text after 24 h of serum starvation. Isolation of Buoyant Fractions by Sucrose Gradient Centrifugation—After treatment, low buoyant fractions were isolated by two different methodologies. The first is based upon the detergent-free method originally described by Song et al. (8Song K.S. Li S. Okamoto T. Quilliam L.A. Sargiacomo M. Lisanti M.P. J. Biol. Chem. 1996; 271: 9690-9697Abstract Full Text Full Text PDF PubMed Scopus (924) Google Scholar). Briefly, A7r5 cells were washed twice with cold phosphate-buffered saline followed by the addition of 500 mm sodium carbonate buffer (pH = 11.0) containing 1 mm sodium orthovanadate, 1mm phenylmethylsulfonyl fluoride, 1 mm β-glycerolphosphate, and a protease inhibitor tablet (Roche Applied Science). Cell lysates were subsequently homogenized using a Dounce glass homogenizer followed by sonication with three 15-s bursts. The lysates were then mixed with equal volumes of 90% sucrose in MBS buffer (25 mm MES, pH 6.5, 150 mm NaCl) and layered at the bottoms of ultracentrifuge tubes. Samples were then overlaid with 4 ml of 35% and 4 ml of 5% sucrose MBS-carbonate buffer. The samples were centrifuged at 35,000 rpm for 20 h at 4 °C using a Beckman swinging bucket rotor (SW41ti). 1-ml fractions were collected from the top down of each gradient. An additional methodology to obtain buoyant fractions was also employed, based upon Tween 20 solubility, originally described by Ref. 9Schuck S. Honsho M. Ekroos K. Shevchenko A. Simons K. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 5795-5800Crossref PubMed Scopus (564) Google Scholar with some modifications. Here, after treatment, A7R5 cells were lysed in 2 ml of MBS (25 mm MES, pH 6.5, 150 mm NaCl, 2 mm EDTA) containing 0.5% Tween 20, 1 mm phenylmethylsulfonyl fluoride, 1 mm NaVO3, 1mm β-glycerolphosphate, and a protease inhibitor tablet (Roche Applied Science). The lysate was subsequently homogenized using a Dounce glass homogenizer followed by sonication with three 15 s bursts. Cell lysates were mixed 1:1 (v/v) with 80% sucrose in MBS (final 40% sucrose) and loaded into Beckman ultracentrifuge tubes. The 40% sucrose solution was then overlaid with 4 ml of 30% sucrose in MBS followed by 4 ml of 5% sucrose in MBS to form a 5–30–40% discontinuous sucrose gradient. Samples were centrifuged at 35,000 rpm for 18 h using a SW41ti rotor. The 12-ml gradient was then fractionated into 1-ml fractions. All gels included a protein lysate control to ensure equivalent visualization between gels. Aliquots of each fraction were immunovisualized by Western blotting and quantified by laser densitometry. Co-immunoprecipitation—Lysates from A7r5 cells were with or The was to each and for 2 were then by and washed twice with with and to Western blotting with a or of cells were in and followed by a serum starvation. Cells were subsequently treated as described in the text and washed twice with cold phosphate-buffered saline followed by the addition of detergent-free buffer mm 150 mm NaCl, mm 1 mm β-glycerolphosphate, protease inhibitor (Roche Applied Cell lysates were homogenized by Dounce and then centrifuged at for 1 The was The was in detergent-free buffer and to The was and the was in buffer and for the was centrifuged at rpm for The was collected and by Western Western were as described previously (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar) with some modifications. Briefly, after treatment, cells were washed with cold phosphate-buffered saline followed by the addition of cold buffer 20 mm 150 mm NaCl, 1 mm 1 mm mm β-glycerolphosphate, 1 mm protease inhibitor and 1 mm phenylmethylsulfonyl in pH Cells were lysed for 15 and cell lysate was and centrifuged at for at 4 Cell lysate or sucrose gradient fractions were loaded in 4–12% precasted SDS-polyacrylamide gel electrophoresis gradient and the proteins were to C membranes The membranes were in 5% in saline containing Tween 20 for 1 h and then with the antibody at 4 the membranes were washed with saline The membranes were then with the antibody for h at three with saline containing Tween 20, the protein were by the enhanced chemiluminescence method and by laser densitometry. Akt3 was from human smooth muscle cell by methodologies. Akt3 was into with a epitope by to the C was to to or All were by the of the of of The was by J. A. Biol. Full Text Full Text PDF PubMed Google Scholar). cells were by an from or from Applied For A7r5 cells were to and with a of to was as described previously (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). Briefly, cells were in a and to 24 h of serum starvation. serum cells were treated with C6-ceramide for 1 h followed by treatment platelet-derived growth for an additional proliferation was with the addition of for the 4 h of Cells were washed with cold and then with cold for 20 Cells were with for and into was with a of with and were using A was are at the from at = C6-ceramide to been demonstrated by that ceramide in lipid microdomains as a of activity or J. R. G. J. Neurosci. Res. 2003; PubMed Scopus (54) Google Scholar). We now that microdomains are with ceramide in A7r5 vascular smooth muscle A7r5 are treated with NBD-C6-ceramide, the of C6-ceramide was in the low buoyant fractions 4 and isolated by a sodium carbonate discontinuous sucrose gradient. C6-ceramide within the low buoyant fractions within and for at 4 h after results were obtained with a C6-ceramide not We the of caveolin-1 and 14-3-3 within a discontinuous sucrose gradient. is a common protein that is a protein for and also as a scaffolding protein T. A. Lisanti M.P. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google whereas 14-3-3 is scaffold protein D. Sci. Scholar). Western of sucrose fractions an of caveolin-1 in fractions 4 and that we isolated buoyant In 14-3-3 is localized to fractions C6-ceramide 1 treatment of A7r5 cells not the or of caveolin-1 or These data that C6-ceramide to the low buoyant fractions that are with caveolin-enriched Ceramide PKCζ from 14-3-3 14-3-3 proteins have been demonstrated to including PKC D. Sci. 2005; Scholar). ceramide not the or of 14-3-3, specifically the association of PKCζ with 14-3-3 PKCζ and were for 14-3-3 a scaffolding protein that was not with these microdomains Ceramide reduced the interaction of PKCζ, but not with 14-3-3, To that ceramide reduced an interaction between 14-3-3 and an activated PKCζ, we in which we now with antibody and with a antibody C6-ceramide treatment reduced the interaction between 14-3-3 and the activated These were the C6-ceramide was in a serum or a The that C6-ceramide treatment not the of 14-3-3 that 14-3-3 and upon C6-ceramide is that ceramide specifically activated PKCζ to may in by of PKCζ from scaffold including 14-3-3, that are not with structured membrane or reside or with the of PKCζ from 14-3-3 may as a to ensure activation of Ceramide PKCζ within (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google we now that ceramide, as as that ceramide and PKCζ phosphorylation at In not PKCζ phosphorylation in A7r5 Western were and for PKCζ be that ceramide, and PKCζ phosphorylation and not PKCζ from the cytosol to the also be that these using as a for activated PKCζ ceramide activation of PKCζ in and in using or recombinant PKCζ (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). To the of and activation of PKCζ, we discontinuous sucrose and the phosphorylation of PKCζ at As in ceramide increased the phosphorylation of PKCζ in the low buoyant fractions 4 and In was a in ceramide-induced PKCζ phosphorylation in fractions 4 and with the control with these also a of phosphorylated PKCζ to the low buoyant fractions. These results suggest that the ceramide localized PKCζ is In the discontinuous sucrose gradient A7r5 VSM cells were fractionated with a sodium carbonate which membrane and To further of activated PKCζ to ceramide-enriched we a methodology to lipid Using this method of sucrose gradient was a localization of caveolin-1 in fraction In A7r5 activated PKCζ was localized in fractions upon treatment with ceramide or was an in the of in fractions with the in fraction with ceramide and to an in the of in fractions with Sucrose gradient fractions of the lysates of cells of the whereas fractions of lysates from ceramide and cells and of the results with the detergent-free ceramide and treatment to a and in the of in the buoyant fractions with that of To further PKCζ activation within ceramide-enriched A7r5 cells were with a PKCζ sucrose gradient that a of PKCζ localized to the domain and ceramide, which localized within fraction 4 and increased the of PKCζ within the the detergent-free sucrose gradient ceramide treatment to a in the of PKCζ in fractions 4 and with cells in sucrose gradient the of PKCζ in the fractions increased from to after treatment with ceramide These data further the that the of PKCζ to the structured ceramide-enriched may be necessary for PKCζ activation and not membrane for PKCζ and Akt are microdomains that are in lipids including and of the lipid is the addition of which the cell of M.P. J. Res. Full Text PDF PubMed Google Scholar). We have previously demonstrated that ceramide-activated PKCζ Akt phosphorylation (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). To ceramide-enriched structured microdomains are necessary for PKCζ-dependent Akt inactivation, we PKCζ phosphorylation as as Akt phosphorylation after with C6-ceramide PKCζ phosphorylation which with inhibition in phosphorylation of phosphorylation of PKCζ was reduced in the of with also the in Akt In the of MβCD, ceramide not further Akt phosphorylation ceramide was to also be that disruption also reduced Akt but not growth which is of not These data the that ceramide-enriched structured microdomains are necessary for ceramide Akt3 Ser34 and for Ceramide of Akt as as to at and which activation of of Akt of inactivation have also been activation of PKCζ to inactivation of phosphorylation of within the domain of phosphorylation in binding to phosphatidylinositol a necessary for Akt activation E. G. Cell Biol. 2003; PubMed Scopus Google Scholar). Here, we proposed that a for the in vascular smooth muscle cells L. Kester M. Biochem. Res. PubMed Scopus Google which an Ser34 in the As Akt leads to VSM growth were by is that Akt a as a cell kinase and been in cell proliferation in different cell including vascular smooth muscle To demonstrate that Ser34 phosphorylation is for ceramide-induced growth we A7r5 cells with a or a Akt The Akt a at to phosphorylation at this which the to inactivate Akt. In these equal and for Akt was using a antibody not In A7r5 cells with a increased which was by ceramide The in mitogenesis with ceramide in vivo that C6-ceramide from as as Akt in vivo (1Charles R. Sandirasegarane L. Yun J. Bourbon N. Wilson R. Rothstein R.P. Levison S.W. Kester M. Circ. Res. 2000; 87: 282-288Crossref PubMed Scopus (54) Google Scholar). the A7r5 cells were with the Akt3 increased Ceramide not further the To further this we demonstrate that Ser34 phosphorylation is also for ceramide-induced inactivation of Akt. Using the with the we initial (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar) that activated Akt and ceramide reduced this activation of Akt upon of the Akt increased Akt activation and ceramide further reduced the phosphorylation of Akt. To address the of phosphorylation of Ser34 is necessary for inactivation of Akt by ceramide, we a to at to phosphorylation and subsequent inactivation of In to and directly to the A7r5 cells the to PDGF, but the ability of ceramide to inactivate as by is now Taken together, these data suggest that ceramide-dependent PKCζ phosphorylation of Akt3 at Ser34 is necessary for ceramide-induced vascular smooth muscle cell growth arrest. In addition, these data that the of ceramide by ceramide into or activating S. S. Biochem. PubMed Google Scholar, A. S. PubMed Scopus Google Scholar, A. P. Kester M. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). The mechanisms by which ceramide including and growth have been Both biophysical (lipid microdomains) and biochemical (ceramide binding targets) mechanisms have been proposed to address this issue. The present study presents an integrated version of these theories. and have previously demonstrated that ceramide as as ceramide to the activation of PKCζ in vitro and in vivo (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar, 3Bourbon N.A. Yun J. Kester M. J. Biol. Chem. 2000; 275: 35617-35623Abstract Full Text Full Text PDF PubMed Scopus (196) Google Scholar, 4Wang Y.M. Seibenhener M.L. Vandenplas M.L. Wooten M.W. J. Neurosci. Res. 1999; 55: 293-302Crossref PubMed Scopus (125) Google Scholar). in leads to inhibition of cell a phosphatidylinositol inactivation of the in vascular smooth muscle cells (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar). We now that ceramide results in an increased localization and phosphorylation of PKCζ within lipid microdomains to inactivate a biophysical and a biochemical for ceramide-induced growth arrest. the inhibition of Akt by ceramide been demonstrated by including mechanisms have been These mechanisms by which ceramide PKCζ (2Bourbon N.A. Sandirasegarane L. Kester M. J. Biol. Chem. 2002; 277: 3286-3292Abstract Full Text Full Text PDF PubMed Scopus (213) Google Scholar, 3Bourbon N.A. Yun J. Kester M. J. Biol. Chem. 2000; 275: 35617-35623Abstract Full Text Full Text PDF PubMed Scopus (196) Google Scholar, 4Wang Y.M. Seibenhener M.L. Vandenplas M.L. Wooten M.W. J. Neurosci. Res. 1999; 55: 293-302Crossref PubMed Scopus (125) Google Scholar, 5Wang G. Silva J. Krishnamurthy K. Tran E. Condie B.G. Bieberich E. J. Biol. Chem. 2005; 280: 26415-26424Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar, 6Muller G. Ayoub M. Storz P. Rennecke J. Fabbro D. Pfizenmaier K. EMBO J. 1995; 14: 1961-1969Crossref PubMed Scopus (475) Google J. Biol. Chem. Full Text PDF PubMed Google and R. D. G. J. G. J. Neurosci. Res. 2005; PubMed Scopus Google Scholar). We now suggest that a of these mechanisms may be the localization of ceramide within lipid the that ceramide Akt activation in an via an inhibition of S. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). been demonstrated that a protein of directly PP2A, ability to Akt L. Cell Biol. 2003; PubMed Scopus Google Scholar). Furthermore, ceramide also been demonstrated to into these which Akt activation by R. D. G. J. G. J. Neurosci. Res. 2005; PubMed Scopus Google Scholar). Here, we have demonstrated that ceramide results in increased phosphorylated PKCζ within lipid We have detergent-free and sucrose gradient strategies to as as the detergent-free sodium carbonate at pH = whereas the used Tween 20 at pH we the using two for two of an activated membrane We that a of ceramide in vascular smooth muscle cells is to localize a phosphorylated form of PKCζ within low buoyant caveolin-enriched lipid by the and of from 14-3-3, a yet scaffolding to in to as Akt to growth arrest. We also that ceramide-activated growth is by the phosphorylation of Akt3 at further the previously by the which demonstrated that ceramide PKCζ phosphorylation of at and subsequent inhibition of activation E. G. Cell Biol. 2003; PubMed Scopus Google Scholar). the of Akt3 was to a to proliferation was in the of Furthermore, in cells this phosphorylation of the activating was ceramide-induced Akt inactivation is a necessary of VSM growth arrest. we demonstrate a for PKCζ and Akt in the of ceramide, is to be this We other proteins as which with PKCζ to form a pro-apoptotic in response to ceramide Y.M. Seibenhener M.L. Vandenplas M.L. Wooten M.W. J. Neurosci. Res. 1999; 55: 293-302Crossref PubMed Scopus (125) Google Scholar, 5Wang G. Silva J. Krishnamurthy K. Tran E. Condie B.G. Bieberich E. J. Biol. Chem. 2005; 280: 26415-26424Abstract Full Text Full Text PDF PubMed Scopus (135) Google Scholar). of activated PKCζ within microdomains is further by a study that upon PKCζ within lipid microdomains A. G. A. 2005; PubMed Scopus Google Scholar). this study not the of ceramides in this other have demonstrated that interactions to ceramide, which is of into where the proteins of the of R. J. 2002; PubMed Scopus Google Scholar, A. N. J. E. R. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). These also suggest that ceramide may binding interactions between PKCζ and in the Akt including kinase which interact with and activate PKCζ by J. A. Biol. Full Text Full Text PDF PubMed Google Scholar, P. PubMed Scopus Google Scholar). these to a common that and localization of ceramide within be the to interaction with ceramide interactions with the of including K. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar, A. J. Biol. Chem. Full Text PDF PubMed Google kinase of S. S. S. M. R. Full Text Full Text PDF PubMed Scopus Google M. J. Biol. 2002; PubMed Scopus Google A. A. J. J. PubMed Scopus Google M. M. S. T. J. P. M. S. Biol. 2000; PubMed Google N.A. Yun J. Kester M. J. Biol. Chem. 2000; 275: 35617-35623Abstract Full Text Full Text PDF PubMed Scopus (196) Google Scholar, S. S. A. J. Google E. G. D. G. N. P. A. A. Biol. 14: PubMed Scopus Google protein kinase J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google M. Biochem. Res. PubMed Scopus Google and PKC G. Ayoub M. Storz P. Rennecke J. Fabbro D. Pfizenmaier K. EMBO J. 1995; 14: 1961-1969Crossref PubMed Scopus (475) Google including PKCζ, have been the of ceramide within lipid microdomains may the ability of ceramide to interact with a as the as kinase of and K. M. N. N. J. Biol. Chem. 2002; 277: Full Text Full Text PDF PubMed Scopus Google Scholar). Taken together, the by which PKCζ is activated within ceramide-enriched microdomains further the of ceramide as an for the and of these interactions to the of selective or of these

References

36